Although elevated circulating FGF21 levels have been observed in RA and associated with altered body composition, reduced physical function, and increased inflammatory cytokines [41,42,43], its prognostic value for LVDD and heart failure in RA has not been investigated. This evidence concerns the gene FGF21 and rheumatoid arthritis.